Open roles at Pathos AI
Latest Pathos AI Signals
What they do
Pathos AI has raised $237 million in a Series E funding round, achieving a valuation of $3 billion. Led by Bristol Myers Squibb Co., this round also included participation from AstraZeneca PLC, NEA, and General Atlantic. The funds will be used to expand Pathos' AI-driven drug development platform, Foundry, and advance its clinical-stage oncology programs.
Why it matters
Pathos AI has developed Foundry, an advanced AI platform that leverages approximately 200 petabytes of oncological data to enhance drug discovery and clinical trial planning. The platform employs specialized AI agents to identify promising drug candidates and optimize patient selection for therapies, fundamentally transforming the drug development process.
Traction
Pathos AI is actively advancing four clinical-stage oncology assets, including a first-in-class antibody-drug conjugate targeting solid tumors. The company is strategically collaborating with major pharmaceutical players like AstraZeneca to enhance its drug development capabilities, indicating strong industry validation and a robust pipeline.
Where the market is going
Pathos AI is positioned to disrupt traditional oncology drug development by integrating AI at every stage, from candidate identification to clinical trial execution. This approach threatens established pharmaceutical methodologies, particularly those of incumbents like Pfizer and Merck, by promising faster and more efficient pathways to market for innovative cancer therapies.
Why Pathos AI is hiring
Pathos AI closed a $237M funding round in October 2026, with investors including Bristol Myers Squibb Co., AstraZeneca PLC, NEA and others. It currently has 5 open roles, with hiring concentrated in New York and New York City. Companies tend to grow headcount fastest in the months after a round, so now is a good time to apply.
Teams hiring
Where Pathos AI hires
Similar Health companies hiring
Pathos AI jobs: common questions
Is Pathos AI hiring?
Yes. Pathos AI has 5 open roles on SuperAIJobs right now. The list is refreshed daily from Pathos AI’s own careers site.
Where are Pathos AI jobs located?
Most open roles at Pathos AI are in New York and New York City.
Does Pathos AI hire remotely?
None of Pathos AI’s current roles are listed as remote, so expect to work from one of its offices.
How much has Pathos AI raised?
The latest round we track is a $237M funding round in October 2026. Investors include Bristol Myers Squibb Co., AstraZeneca PLC, NEA and others. See the full deal history on MapCo.
What does Pathos AI do?
Pathos AI has developed Foundry, an advanced AI platform that leverages approximately 200 petabytes of oncological data to enhance drug discovery and clinical trial planning.
How do I apply for a job at Pathos AI?
Every role on this page links straight to Pathos AI’s own application page, so you apply directly — SuperAIJobs never sits in between.